De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma. (December 2017) - Carney, Brian J.; Rangachari, Deepa; VanderLaan, Paul A.; Gowen, Kyle; Schrock, Alexa B.; Ali, Siraj M.; Costa, Daniel B.